Inhibition of neuronal death by promoting degradation of intracellular amyloid β-protein

Yasumasa Ohyagi, Katsue Miyoshi, Linqing Ma, Kyoko Motomura, Jun Ichi Kira

研究成果: Contribution to journalReview article査読


Inhibition of aggregation of amyloid β-protein (Aβ) and promotion of extracellular Aβ removal are known as potent therapeutic tools for Alzheimer's disease (AD). While, the importance of Aβ42 accumulating in neurons has recently been suggested, and we have reported that Aβ42 accumulating in the neurons moves into the nucleus, activating p53 mRNA expression and leading to apoptosis (Ohyagi et al, FASEB J, 2005). Moreover, intraneuronal Aβ is reported to induce mitochondrial dysfunction via binding ABAD, synaptic pathology, and inhibition of proteasome. Thus, it is an alternative therapeutic tool to decrease the levels of Aβ42 and p53 proteins in AD neurons. We established a human neuroblastoma (SH-SY5Y) cell culture system in which Aβ peptide is artificially accumulated in cytosol. We have found that apomorphine hydrochloride promotes degradation of intracellular Aβ and p53 attenuating oxidative stress-induced apoptosis. Using a proteasome activity assay method, one of the mechanisms is thought to be activation of proteasome. Similar anti-apoptotic effect was observed in the primary cultured neurons. Apomorphine hydrochloride is now used as a dopamine agonist for Parkinson's disease or an anti-ED drug in western countries, but also may be one of the candidate drugs to inhibit neuronal death in AD.

ジャーナルJapanese Journal of Neuropsychopharmacology
出版ステータス出版済み - 4 2007

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

フィンガープリント 「Inhibition of neuronal death by promoting degradation of intracellular amyloid β-protein」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。